Renal Division, Department of Medicine, Peking University First Hospital, Beijing, 100034, China.
Institute of Nephrology, Peking University, Beijing, 100034, China.
Sci Rep. 2021 Feb 11;11(1):3615. doi: 10.1038/s41598-020-79331-w.
Genes of UMOD, HNF1B, MUC1, REN and SEC61A1 were reported to be associated with autosomal dominant tubulointerstitial kidney disease (ADTKD). 48 probands and their family members (N = 27) were enrolled in this genetic screening study. A combination of methods was employed for comprehensive molecular analysis of both copy number variations (CNVs) and single nucleotide variants (SNVs). 35 probands were followed for years. The phenotype-genotype and genotype-outcome correlation were inferred from these datasets. In this cohort, 18 probands were diagnosed with ADTKD, according to Kidney Disease: Improving Global Outcomes (KDIGO) guideline. Moreover, 11 probands were diagnosed with ADTKD-UMOD, one with ADTKD-REN and one with ADTKD-HNF1B, based on molecularly confirmed pathogenic variants. The 11 UMOD variants were mainly located in codons 28 to 289 and half of the variants were found to change the cysteine amino acid. According to the follow-up data, suspected ADTKD individuals had a better prognosis compared to ADTKD individuals (p = 0.029). Individuals with a cysteine substitution in the UMOD gene appeared to have a better prognosis than individuals with other amino acid substitutions (p = 0.015).
UMOD、HNF1B、MUC1、REN 和 SEC61A1 的基因与常染色体显性遗传性肾小管间质性肾病(ADTKD)有关。48 名先证者及其家庭成员(N=27)参与了这项遗传筛查研究。采用了多种方法对拷贝数变异(CNVs)和单核苷酸变异(SNVs)进行全面的分子分析。对 35 名先证者进行了多年的随访。从这些数据集中推断了表型-基因型和基因型-结果的相关性。在该队列中,根据肾脏病:改善全球预后(KDIGO)指南,18 名先证者被诊断为 ADTKD。此外,根据分子证实的致病性变异,11 名先证者被诊断为 ADTKD-UMOD、1 名被诊断为 ADTKD-REN、1 名被诊断为 ADTKD-HNF1B。11 种 UMOD 变异主要位于 28 至 289 位密码子,其中一半的变异导致半胱氨酸氨基酸发生变化。根据随访数据,疑似 ADTKD 个体的预后优于 ADTKD 个体(p=0.029)。在 UMOD 基因中存在半胱氨酸取代的个体似乎比其他氨基酸取代的个体具有更好的预后(p=0.015)。